US2017252307A1PendingUtilityA1

Detrusor hyperactivity with impaired contractility ameliorating agent

Assignee: TAIHO PHARMACEUTICAL CO LTDPriority: Aug 4, 2015Filed: May 19, 2017Published: Sep 7, 2017

Est. expiryAug 4, 2035(~9 yrs left)· nominal 20-yr term from priority

Inventors:Yukio Hayashi Takahisa Noma

A61P 13/00A61K 31/122A61K 47/00A61P 13/10

PatentIndex Score

Cited by

References

Claims

Abstract

This invention is directed to a treating method for DHIC, comprising the step of administering a therapeutically effective amount of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexene-1-one, a salt thereof, or a solvate thereof.

Claims

exact text as granted — not AI-modified

1 . A method for treating a disorder that presents both detrusor overactivity and detrusor impaired contractility, comprising the step of administering a therapeutically effective amount of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexene-1-one, a salt thereof, or a solvate thereof. 
     
     
         2 . A method for treating detrusor hyperactivity with impaired contractility, comprising the step of administering a therapeutically effective amount of 3-(15-hydroxypentadecyl)-2,4,4-trimethyl-2-cyclohexene-1-one, a salt thereof, or a solvate thereof, to a patient with detrusor hyperactivity with impaired contractility.

Join the waitlist — get patent alerts

Track US2017252307A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.